MAP Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
MAP Pharmaceuticals, Inc.
CIK #0001401923
EDGAR Form CIK 2011 - 2025
10-K [0001401923]
10-Q [0001401923]
3 [0001401923]
4 [0001401923]
5 [0001401923]
8-K [0001401923]
SC 13D [0001401923]
SC 13G [0001401923]
Form 13D/13G Filer Form 13D/13G Subject Filed
OrbiMed Advisors LLC MAP Pharmaceuticals Inc [2013-02-14]
Price T Rowe Associates Inc /MD/ MAP Pharmaceuticals Inc [2013-02-12]
BlackRock Inc MAP Pharmaceuticals Inc [2013-01-30]
Gamco Investors Inc ET AL MAP Pharmaceuticals Inc [2013-01-30]
Allergan Inc MAP Pharmaceuticals Inc [2013-01-29]
Form 3/4/5 Subject 2011 - 2025
MAP Pharmaceuticals, Inc.
McPherron Matthew V
Chai Christopher Y
Kelley Bernard J
Nelson Timothy S
Armer Thomas A
Friedman Charlene A
Gianakakos Anastasios
Kellerman Donald J
Borland Scott
View All
Terms | Privacy | Guide
tony@aum13f.com